TREATMENT OPTIONS FOR IRON DEFICIENCY ANEMIA IN CHILDREN IN SAUDI ARABIA
Main Article Content
Keywords
anemia, iron-deficiency, Children, iron defieciecy in Saudi Arabia, therapy, iron deficiency treatment options
Abstract
Background: Iron deficiency anaemia (IDA) is the most common haematological disorder in children, with a prevalence of 20.1% between the ages of 0 and 4 and 5.9% between the ages of 5 and 14 (39 and 48.1% in developing countries).
Methods: The laboratory reveals microcytic-hypochromic anaemia (low Hb, MCV, MCH, and RDW) with a low reticulocyte count. Low ferritin, sideremia, transferrin saturation, and high unsaturated serum transferrin levels are all observed.
Results: Every day, new frontiers in its diagnosis and therapeutic options emerge; recently, innovative iron formulations for oral and parenteral administration have been launched, with the goal of offering treatment schedules with higher efficacy and lower toxicity.
Conclusion: The current article reports the most recent clinically relevant findings regarding IDA in children and provides practical guidance, particularly in selecting the most appropriate therapy strategies.
References
2. Al-Sheikh MH. Prevalence and risk factors of iron-deficiency anemia in Saudi female medical students. Prevalence. 2018;7:148–52.https://doi.org/10.4103/sjhs.sjhs_79_18
3. Wang Y., Wu Y., Li T., Wang X., Zhu C. Iron Metabolism and Brain Development in Premature Infants. Front. Physiol. 2019;10:463. doi: 10.3389/fphys.2019.00463
4. Srivaths L., Minard C.G., O’Brien S.H., Wheeler A.P., Mullins E., Sharma M., Sidonio R., Jain S., Zia A., Ragni
5. M.V., et al. The spectrum and severity of bleeding in adolescents with low von Willebrand factor-associated heavy menstrual bleeding. Blood Adv. 2020;4:3209–3216.
6. Pereira A.D.S., de Castro I.R.R., Bezerra F.F., Neto J.F.N., da Silva A.C.F. Reproducibility and validity of portable haemoglobinometer for the diagnosis of anaemia in children under the age of 5 years. J. Nutr. Sci. 2020;9:e3. doi: 10.1017/jns.2019.43.
7. Stoffel N.U., Cercamondi C.I., Brittenham G., Zeder C., Geurts-Moespot A.J., Swinkels D.W., Moretti D., Zimmermann M.B. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: Two open-label, randomised controlled trials. Lancet Haematol. 2017;4:e524–e533. doi: 10.1016/S2352-3026(17)30182-5.
8. Alquaiz AJ, Khoja TA, Alsharif A, et al. Prevalence and correlates of anaemia in adolescents in Riyadh city, Kingdom of Saudi Arabia. Public Health Nutr. 2015;18:3192–3200.
9. Shah Y, Patel D, Khan N. Iron deficiency anemia in IBD: an overlooked comorbidity. Expert Rev Gastroenterol Hepatol 2021;15:771–81. 10.1080/17474124.2021.1900730
10. Richards T, Baikady RR, Clevenger B, et al. Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT): a randomised, double-blind, controlled trial. Lancet 2020; published online Sept 4. https://doi.org/10.1016/ S0140-6736(20)31539-7.
11. Klein K, Asaad S, Econs M, Rubin JE. Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration. BMJ Case Rep 2018; 2018: bcr2017222851.
12. Muñoz M., Gómez-Ramírez S., Bhandari S. The safety of available treatment options for iron-deficiency anemia. Expert Opin. Drug Saf. 2018;17:149–159. doi: 10.1080/14740338. 2018.1400009.
13. O’Lone EL, Hodson EM, Nistor I, Bolignano D, Webster AC, Craig JC. Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev 2019; 2: CD007857.
14. Giordano G, Napolitano M, Di Battista V, et al.. Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant/refractory to iron sulfate: a multicentric randomized study. Ann Hematol 2021;100:2173–9. 10.1007/s00277-020-04361-3
15. Valentine S, Bembea M, Muszynski J, et al. Consensus recommendations for RBC transfusion practice in critically ill children from the pediatric critical care transfusion and anemia expertise initiative. Pediatr Crit Care Med 2018; 19: 884e98.
16. Ponikowski P, Kirwan B-A, Anker SD, et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 2020; published online Nov 13. https://doi.org/10.1016/ S0140-6736(20)32339-4.
17. Muszynski J, Guzzetta N, Hall M, et al. Recommendations on RBC transfusions for critically ill children with nonhemorrhagic shock from the pediatric critical care transfusion and anemia expertise initiative. Pediatr Crit Care Med 2018; 19(suppl 1): S121e6.
18. Ko CW, Siddique SM, Patel A, et al. AGA Clinical practice guidelines on the gastrointestinal evaluation of iron deficiency anemia. Gastroenterology 2020; 159: 1085–94.
19. Sultan P, Bampoe S, Shah R, et al. Oral vs intravenous iron therapy for postpartum anemia: a systematic review and meta-analysis. Am J Obstet Gynecol 2019; 221: 19–29.e3.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Asmaa Saad Abdul Rahman Al-Asmari
Pharmacy technician, Prince Mohammed bin Abdulaziz Hospital
Yousra Khaled Al-Anzi
Pharmacist, Prince Mohammed bin Abdulaziz Hospital
Mohammed zaid Ibrahim Aoqayli
Nursing technician, Hotat Bani Tamim Hospital
Ali Muhammad Ali Alshgahterh
Nursing technician, Hotat Bani Tamim Hospital
Abdullah Ibrahim Abdullah Aoqayli
Nursing technician, Hotat Bani Tamim General Hospital